Allergy medication recalled after drug mix-up that could be life-threatening: FDA

Unique Pharmaceutical Laboratories has issued a voluntary recall for four lots of its 5 mg Cetirizine Hydrochloride tablets. This decision follows the discovery of cross-contamination with Ranitidine, a drug primarily used to manage heartburn and severe acid reflux.

The Food and Drug Administration flagged this issue due to the potential health risks for consumers. The agency states that this mix-up is dangerous, particularly for individuals who possess a hypersensitivity to certain ingredients found in these medications.

Consumers should check their medicine cabinets immediately for the affected Cetirizine lots. The recall process began on July 18 and is currently active at the consumer level. Please consult with your pharmacist or healthcare provider if you have questions regarding the safety of your current allergy treatment.

This is a developing safety notice from the FDA. Stay informed on product recalls to protect your health.